Dr. Yacoubian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Summary
- John A. and Ruth R. Jurenko Endowed Professor in Neurology
Education & Training
- University of Alabama Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2006 - 2007
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2005 - 2006
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2002 - 2005
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Nuclear Medicine, 2002 - 2005
- Brigham and Women's HospitalInternship, Internal Medicine, 2001 - 2002
- Duke University School of MedicineClass of 2001
Certifications & Licensure
- AL State Medical License 2006 - 2024
- MA State Medical License 2005 - 2007
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Clinical Trial Readiness for SCA1 and SCA3 Start of enrollment: 2018 Aug 16
Publications & Presentations
PubMed
- 14-3-3 phosphorylation inhibits 14-3-3θ's ability to regulate LRRK2 kinase activity and toxicity.Rudradip Pattanayak, Roschongporn Ekkatine, Chad M Petit, Talene A Yacoubian
Human Molecular Genetics. 2024-11-20 - 1 citationsThe Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias.Louisa P Selvadurai, Susan L Perlman, Tetsuo Ashizawa, George R Wilmot, Chiadi U Onyike
Cerebellum. 2024-08-01 - 1 citationsSingle molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation.Yuan Yuan, Huizhong Li, Kashyap Sreeram, Tuyana Malankhanova, Ravindra Boddu
Molecular Neurodegeneration. 2024-06-11
Journal Articles
- 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic Alpha-SynucleinTalene Yacoubian, MD, The Journal of Neuroscience
Press Mentions
- $25,000 -- It's a Start to Battle Brain Disease and UAB Is on ItAugust 27th, 2018
- APDA Funded Research Suggests New Approach to Understanding the Basic Biology of PDAugust 13th, 2018
- Reduced Levels of Chaperone Protein May Have Implications for Development of Parkinson’s DiseaseAugust 10th, 2018
- Join now to see all
Grant Support
- Role Of 14-3-3 Proteins In Alpha-Synuclein-Induced NeurotoxicityNational Institute Of Neurological Disorders And Stroke2008–2012
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: